Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonDividends Paid - PreferredFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Gains from Sales and Divestitures: 2009-2025

Historic Gains from Sales and Divestitures for Amdocs (DOX) over the last 16 years, with Sep 2025 value amounting to $932,000.

  • Amdocs' Gains from Sales and Divestitures fell 14.26% to $932,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $932,000, marking a year-over-year decrease of 14.26%. This contributed to the annual value of $932,000 for FY2025, which is 9.01% up from last year.
  • Per Amdocs' latest filing, its Gains from Sales and Divestitures stood at $932,000 for FY2025, which was up 9.01% from $855,000 recorded in FY2024.
  • Over the past 5 years, Amdocs' Gains from Sales and Divestitures peaked at $1.1 million during FY2023, and registered a low of $855,000 during FY2024.
  • Its 3-year average for Gains from Sales and Divestitures is $956,333, with a median of $932,000 in 2025.
  • In the last 5 years, Amdocs' Gains from Sales and Divestitures climbed by 22.73% in 2022 and then fell by 20.98% in 2024.
  • Amdocs' Gains from Sales and Divestitures (Yearly) stood at $880,000 in 2021, then increased by 22.73% to $1.1 million in 2022, then rose by 0.19% to $1.1 million in 2023, then fell by 20.98% to $855,000 in 2024, then increased by 9.01% to $932,000 in 2025.